Literature DB >> 8049459

Biological factors of prognostic significance in locally advanced breast cancer.

J F Robertson1, I O Ellis, D Pearson, C W Elston, R I Nicholson, R W Blamey.   

Abstract

The biological features of tumour type, histological grade, vascular invasion, mitotic index, DNA index, and oestrogen receptor (ER) and progesterone receptor (PgR) status have been investigated as prognostic factors in primary operable breast cancer. We have studied these 7 factors in locally advanced primary breast cancer (LAPC): these patients have occult metastases at presentation. Of 60 consecutive patients presenting with locally advanced disease, 36 were treated initially with Tamoxifen and 24 by radiotherapy. Treatment failure was followed by cross-over to the other therapy. All patients were assessed for response in the primary tumour; external review of response was obtained. Survival was compared using the generalised Wilcoxon test. Response to therapy correlated significantly with histological grade (p = 0.02), ER (p = 0.02), PgR status (p = 0.02), mitotic index (p = 0.01), and tumour ploidy (p = 0.04). Survival from initial therapy correlated significantly with ER (p = 0.01) and PgR status (p = 0.04). Histological grade, mitotic index, tumour ploidy, and ER and PgR status of the primary tumour predict response and prognosis in patients with locally advanced (stage III) breast cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049459     DOI: 10.1007/bf00666479

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Prognosis in inoperable stage III carcinoma of the breast.

Authors:  R D Rubens; P Armitage; P J Winter; D Tong; J L Hayward
Journal:  Eur J Cancer       Date:  1977-08       Impact factor: 9.162

3.  Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.

Authors:  J L Hayward; P P Carbone; J C Heuson; S Kumaoka; A Segaloff; R D Rubens
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

4.  Assessment of response to treatment in advanced breast cancer. British Breast Group.

Authors: 
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

5.  The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer.

Authors:  M R Williams; D Gilson; L Marsh; D A Morgan; R I Nicholson; C W Elston; K Griffiths; R W Blamey
Journal:  Eur J Surg Oncol       Date:  1988-06       Impact factor: 4.424

6.  Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.

Authors:  R I Nicholson; P Colin; A B Francis; R Keshra; P Finlay; M Williams; C W Elston; R W Blamey; K Griffiths
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

7.  Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy.

Authors:  J F Robertson; A R Dixon; R I Nicholson; I O Ellis; C W Elston; R W Blamey
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Monoclonal antibodies to human estrogen receptor.

Authors:  G L Greene; C Nolan; J P Engler; E V Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  The definition of the 'no change' category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast.

Authors:  A Howell; J Mackintosh; M Jones; J Redford; J Wagstaff; R A Sellwood
Journal:  Eur J Cancer Clin Oncol       Date:  1988-10

10.  Confirmation of a prognostic index in primary breast cancer.

Authors:  J H Todd; C Dowle; M R Williams; C W Elston; I O Ellis; C P Hinton; R W Blamey; J L Haybittle
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

View more
  4 in total

Review 1.  Preoperative assessment of prognostic factors in breast cancer.

Authors:  H Denley; S E Pinder; C W Elston; A H Lee; I O Ellis
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 2.  Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.

Authors:  C G Kleer; K L van Golen; S D Merajver
Journal:  Breast Cancer Res       Date:  2000-07-11       Impact factor: 6.466

3.  Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers.

Authors:  B Brenner; N Siris; E Rakowsky; E Fenig; A Sulkes; H Lurie
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

4.  Salubrinal Exposes Anticancer Properties in Inflammatory Breast Cancer Cells by Manipulating the Endoplasmic Reticulum Stress Pathway.

Authors:  Andrew Alsterda; Kumari Asha; Olivia Powrozek; Miroslava Repak; Sudeshna Goswami; Alexandra M Dunn; Heidi C Memmel; Neelam Sharma-Walia
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.